Novo Nordisk Pharma (Malaysia) Sdn. Bhd. (Malaysia)

Novo Nordisk Pharma (Malaysia) Sdn. Bhd. is the Malaysian operating subsidiary of Novo Nordisk A/S, a global pharmaceutical company specializing in diabetes care, obesity treatment, rare diseases and other chronic conditions. The company's activities in Malaysia focus on the marketing, distribution and medical support of prescription pharmaceutical products, including insulin therapies, injectable treatments and related healthcare solutions. Its operations support healthcare providers, hospitals and clinics through product supply, medical education and patient support initiatives. Operating within Malaysia's regulated pharmaceutical environment, Novo Nordisk Pharma adheres to stringent regulatory, quality and compliance standards governing drug distribution and promotion. The company's positioning is centered on improving patient outcomes through innovative therapies, scientific expertise and engagement with the healthcare ecosystem. Through its Malaysian presence, Novo Nordisk contributes to chronic disease management, healthcare access and awareness within the country.